findmyKOL
Clinical trialNCT07161544RecruitingPhase 1/PHASE2Interventional

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

SponsorAAVantgarde Bio SrlEnrollment75Stargardt Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United Kingdom
  • Moorfields Eye Hospital Nhs Foundation Trust

    London, England, United Kingdom

    Recruiting
  • the Retina Clinic

    London, England, United Kingdom

    Recruiting
United States
  • Associated Retina Consultants

    Phoenix, Arizona, United States

    Benjamin Bakall
    Recruiting
  • Retina Vitreous Associates Medical Group

    Los Angeles, California, United States

    David Liao
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Brittni Scruggs
    Recruiting
  • Retina Consultants of Texas

    Bellaire, Texas, United States

    Kenneth Fan
    Recruiting
  • Retina Foundation of the Southwest

    Dallas, Texas, United States

    Karl Csaky
    Recruiting
  • University of Utah

    Salt Lake City, Utah, United States

    Paul Bernstein
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
29 Sept 2025
Primary completion
31 Jul 2032
Completion
31 Jul 2032
Last update posted
23 Jun 2026
Registered enrollment
75
Registry id
NCT07161544

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.